{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:14:41Z","timestamp":1761488081916},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,7,14]],"date-time":"2008-07-14T00:00:00Z","timestamp":1215993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,7,14]],"date-time":"2008-07-14T00:00:00Z","timestamp":1215993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1038\/bmt.2008.199","type":"journal-article","created":{"date-parts":[[2008,7,14]],"date-time":"2008-07-14T11:03:34Z","timestamp":1216033414000},"page":"551-552","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation"],"prefix":"10.1038","volume":"42","author":[{"given":"F","family":"Schlemmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Lagrange-X\u00e9lot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"de La Tour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Soci\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-M","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,14]]},"reference":[{"key":"BFbmt2008199_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa061098","volume":"356","author":"AJ Ullmann","year":"2007","unstructured":"Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356: 335\u2013471.","journal-title":"N Engl J Med"},{"key":"BFbmt2008199_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1056\/NEJMoa061094","volume":"356","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ et al. Posaconazole vs fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007; 356: 348\u2013359.","journal-title":"N Engl J Med"},{"key":"BFbmt2008199_CR3","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1128\/JCM.41.8.3623-3626.2003","volume":"41","author":"D Diekema","year":"2003","unstructured":"Diekema D, Messer SA, Hollis RJ, Jones RN, Pfaller MA . Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 2003; 41: 3623\u20133626.","journal-title":"J Clin Microbiol"},{"key":"BFbmt2008199_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/jac\/dkg020","volume":"51","author":"E Dannaoui","year":"2003","unstructured":"Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE . In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003; 51: 45\u201352.","journal-title":"J Antimicrob Chemother"},{"key":"BFbmt2008199_CR5","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1086\/500212","volume":"42","author":"JAH van Burik","year":"2006","unstructured":"van Burik JAH, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP . Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 2006; 42: e61\u2013e65.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2008199_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","volume":"50","author":"RN Greenberg","year":"2006","unstructured":"Greenberg RN, Mullane K, van Burik JAH, Raad I, Abzug MJ, Anstead G et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006; 50: 126\u2013133.","journal-title":"Antimicrob Agents Chemother"},{"key":"BFbmt2008199_CR7","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1056\/NEJM200402263500923","volume":"350","author":"FM Marty","year":"2004","unstructured":"Marty FM, Cosimi L, Baden LR . Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants [letter]. N Engl J Med 2004; 350: 950\u2013952.","journal-title":"N Engl J Med"},{"key":"BFbmt2008199_CR8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1086\/422723","volume":"39","author":"GT Siwek","year":"2004","unstructured":"Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004; 39: 584\u2013587.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2008199_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/sj.bmt.1705614","volume":"39","author":"SM Trifilio","year":"2007","unstructured":"Trifilio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J et al. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant 2007; 39: 425\u2013429.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008199_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.bmt.1705754","volume":"40","author":"S Trifilio","year":"2007","unstructured":"Trifilio S, Singhal S, Williams S, Frankfurt O, Gordon L, Evens A et al. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant 2007; 40: 451\u2013456.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008199_CR11","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1128\/AAC.47.11.3647-3650.2003","volume":"47","author":"E Dannaoui","year":"2003","unstructured":"Dannaoui E, Meis J, Loebenberg D, Verweij PE . Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob Agents Chemother 2003; 47: 3647\u20133650.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2008199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008199","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T11:47:35Z","timestamp":1648036055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2008199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,14]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["BFbmt2008199"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2008.199","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,14]]},"assertion":[{"value":"14 July 2008","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}